HIO offers an attractive 11% yield, but its focus on high-yield, below-investment-grade debt increases risk. Click here to ...

Eton Pharmaceuticals is experiencing explosive rare-disease revenue growth, with a 117% YoY increase and a robust pipeline ...

(" Morningstar ”), the index provider of the Index, announced that effective June 20, 2025: (1) the name of the Index will ...